Additional information
| Strength | 10mg, 2mg |
|---|
B7-33 (Modified Relaxin-2 Analog)
Price range: $58.00 through $200.00
Product Classification
Classified as an RXFP1 pathway peptide analog
Description
B7-33 is a single-chain relaxin analog designed to activate RXFP1 signaling with reduced mitogenic activity compared to native relaxin.
Research focuses on anti-fibrotic mechanisms, extracellular matrix remodeling, and cardiovascular pathways
Specifications
- Molecular Type: Relaxin-2 analog
- Mechanism: RXFP1-mediated anti-fibrotic and vasodilatory signaling
Research Notes
- - Anti-Fibrotic: preclinical models report reduced collagen deposition and fibrosis.
- - ECM Remodeling: influences matrix metalloproteinases and stromal remodeling
- - Cardiovascular: evaluated in heart failure and pulmonary hypertension models
- Mitogenic Sparing: analog design minimizes proliferative signaling of relaxin.
Regulatory Statement
For research use only. Not for human or animal consumption.
Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease
Related products
-
– Cortagen (Cerebroprotein Analogue)
$90.00 Select options This product has multiple variants. The options may be chosen on the product page -
– ACE-031 (Soluble Activin Receptor Type IIB-Fc Fusion Protein)
$40.00 Select options This product has multiple variants. The options may be chosen on the product page -
Dihexa (Nootropic Peptidomimetic)
Price range: $30.00 through $60.00 Select options This product has multiple variants. The options may be chosen on the product page -
CJC-1295 (No DAC) + Ipamorelin
$70.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.